BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 35550147)

  • 1. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A risk signature with four autophagy-related genes for predicting survival of glioblastoma multiforme.
    Wang Y; Zhao W; Xiao Z; Guan G; Liu X; Zhuang M
    J Cell Mol Med; 2020 Apr; 24(7):3807-3821. PubMed ID: 32065482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel risk signature with 6 RNA binding proteins for prognosis prediction in patients with glioblastoma.
    Huang QR; Li JW; Pan XB
    Medicine (Baltimore); 2021 Dec; 100(48):e28065. PubMed ID: 35049227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
    Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
    Front Oncol; 2022; 12():938679. PubMed ID: 35982954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of alternative splicing signatures in the prognosis of glioblastoma.
    Xie ZC; Wu HY; Dang YW; Chen G
    Cancer Med; 2019 Dec; 8(18):7623-7636. PubMed ID: 31674730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new prognostic model for glioblastoma multiforme based on coagulation-related genes.
    Zhou M; Deng Y; Fu Y; Liang R; Liu Y; Liao Q
    Transl Cancer Res; 2023 Oct; 12(10):2898-2910. PubMed ID: 37969372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone acetylation gene-based biomarkers as novel markers of the immune microenvironment in glioblastoma.
    Yan X; Feng L; Xu Z; Chen W; Yan H; Wu P; Ding C; Zhu X; Lu Y
    J Gene Med; 2023 Oct; 25(10):e3511. PubMed ID: 37097165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
    Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
    Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis-related prognosis model, immunocyte infiltration characterization, and competing endogenous RNA network of glioblastoma.
    Ding MR; Qu YJ; Peng X; Chen JF; Zhang MX; Zhang T; Hu B; An HM
    BMC Cancer; 2022 Jun; 22(1):611. PubMed ID: 35658846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An autophagy-related prognostic signature associated with immune microenvironment features of uveal melanoma.
    Zheng Z; Zhang L; Tu Z; Deng Y; Yin X
    Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33682883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of DNA Damage Repair Gene Signature as a Novel Prognostic Marker in Glioblastoma Multiforme.
    Xu G; Deng Y; Shi H
    World Neurosurg; 2023 Aug; 176():e598-e609. PubMed ID: 37270097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses.
    Ye S; Yang B; Zhang T; Wei W; Li Z; Chen J; Li X
    Cells; 2022 Sep; 11(19):. PubMed ID: 36230961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neutrophil extracellular traps-related gene signature predicts the prognosis of glioblastoma multiforme.
    Sun G; Liu W
    Folia Neuropathol; 2024; 62(1):59-75. PubMed ID: 38174685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma.
    Deng J; Zhang Q; Lv L; Ma P; Zhang Y; Zhao N; Zhang Y
    Sci Rep; 2022 Apr; 12(1):7006. PubMed ID: 35488119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma.
    Zhang Q; Lv L; Ma P; Zhang Y; Deng J; Zhang Y
    Front Immunol; 2021; 12():743938. PubMed ID: 34956177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Glucose Metabolism-Related Gene Signature for Overall Survival Prediction in Patients with Glioblastoma.
    Zhang C; Wang M; Ji F; Peng Y; Wang B; Zhao J; Wu J; Zhao H
    Biomed Res Int; 2021; 2021():8872977. PubMed ID: 33553434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.